ArticleMolecular cancer therapeutics2024

Raludotatug Deruxtecan, a CDH6-Targeting Antibody-Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models.

Hirokazu Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.